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Abstract
Bipolar disorder (BD) is an increasingly prevalent diagnosis in youth. As a result, there has been a corresponding
increase in interest about neuropsychological and cognitive profiles in children and adolescents diagnosed with
BD. Meta-analysis of the existing literature comparing individuals with BD to healthy controls indicated that
the largest differences are observed for measures of verbal memory (d  0.77). Moderate differences were found
in the areas of attention (d  0.62), executive functioning (d  0.62), working memory (d  0.60), visual mem-
ory (d  0.51), visual perceptual skills (d  0.48), and verbal fluency (d  0.45). Small differences were found
for measures of reading (d  0.40), motor speed (d  0.33), and full-scale intelligence quotient (IQ) (d  0.32).
Often, few studies have provided relevant information for a particular neurocognitive domain. Despite this,
several domains displayed heterogeneity of effect sizes across studies. Methodological factors explained the
variance in effect sizes to different extents depending upon the cognitive domain. The changing influence of
method artifacts is likely due to variable coverage of cognitive domains across studies and the use of different
measures across studies. Findings are consistent with previous meta-analyses of the adult BD neurocognitive
literature, suggesting that many of the deficits observed in adults are present earlier in the course of the illness.
Study reporting guidelines are offered that may help clarify the impact of illness definitions, mood state, med-
ication status, and other methodological variables on neurocognition in pediatric BD.
595
Cognitive Performance in Pediatric Bipolar Disorder
BIPOLAR DISORDER (BD) IS A CHRONIC, COMPLEX mood dis-order that has been increasingly diagnosed in children
in recent years (Youngstrom et al. 2005; Blader and Carlson
2007; Moreno et al. 2007) and is associated with poor prog-
nosis and outcome (Goodwin and Jamison 2007). The pedi-
atric phenotype pediatric bipolar disorder (PBD), with ill-
ness onset before age 18, may represent an especially
genetically driven form of the disorder (Lin et al. 2006; Rende
et al. 2007) and is associated with increased risk of suicide
and substance abuse, above and beyond levels of risk seen
in BD in general (Lin et al. 2006), as well as behavioral, aca-
demic, social, and legal problems (Birmaher 2007). Poor out-
comes have been demonstrated longitudinally in domains
such as treatment response, recovery rates, and relapse rates;
these outcomes are similar to those seen in adults with se-
vere, treatment-resistant BD (Geller et al. 2000; Geller et al.
2001). Additionally, rates of hospitalization and psychosis in
youths with BD are elevated (Birmaher and Axelson 2006),
and nearly one third of youths with BD have a lifetime his-
tory of attempting suicide (Goldstein et al. 2005).
Understanding the phenomenology of PBD remains a
challenge for the field. The potential cognitive and neu-
ropsychological deficits experienced by these youths has
been attracting increasing amounts of attention. Under-
standing cognitive abnormalities in PBD may lend insight
into the neurobiological systems that are disrupted by this
disorder, as well as provide a link between neurobiology and
observed symptoms and behaviors. This information can
also inform our understanding of the course of the illness
and potentially define endophenotypes for further parsing
of BD (Glahn et al. 2005; Christensen et al. 2006; Antila et al.
2007; Trivedi et al. 2008).
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The study of cognitive and neuropsychological function-
ing in adults with BD suggests that the disorder is associ-
ated primarily with impairments in executive function, ver-
bal learning and memory, and attention (Bearden et al. 2001;
Murphy and Sahakian 2001; Seidman et al. 2002). Two re-
cent meta-analyses comparing those with BD to healthy con-
trols have found large effects for executive measures such as
Category Fluency, Reverse Digit Span, Trail Making Test B,
and Wisconsin Card Sorting Test perseverative errors, as
well as verbal learning measures such as the California Ver-
bal Learning Test (CVLT) (Robinson et al. 2006; Arts et al.
2007). Medium effect sizes were found for deficits on sus-
tained attention tasks. Verbal fluency has been noted as an
area of difficulty and shows small-to-medium effect sizes.
Measures of general cognitive ability or full-scale intelligence
quotient (FSIQ), such as tests of reading or vocabulary, dem-
onstrate the smallest effect sizes.
It is important to understand whether the impairments
suggested by these meta-analyses are similar across the life-
span or whether they may differ for children and adoles-
cents. Congruence between youth and adult neurocognitive
findings would reinforce the similarity in phenotypic defi-
nition across the life cycle, providing “laboratory findings”
that support the validity of the definition of PBD (Robins and
Guze 1970). More nuanced analyses of pediatric neurocog-
nitive data may also help to disentangle whether neurocog-
nitive features represent a diathesis for PBD, versus a pro-
gressive change in brain functioning in response to episodes.
Fewer studies have examined neurocognitive deficits in
pediatric cases than adults with BD. These studies have
yielded findings of impairment in executive function, mem-
ory, attention, and processing speed, as well as differences
in intelligence testing results and academic functioning for
youth with PBD (e.g., Dickstein et al. 2004; Doyle et al. 2005;
McClure et al. 2005a; Bearden et al. 2007). In a qualitative re-
view of PBD neuropsychological functioning, Kyte et al.
(2006) suggest that impairments in attention, decision-mak-
ing, and response inhibition are particularly common. These
authors also suggest that there are greater similarities than
differences in neuropsychological performance between
child, adolescent, and adult BD.
Though there has been progress in understanding neu-
rocognitive functioning in BPD, there are many unanswered
questions about the nature of potential deficits. Namely, the
exact magnitude of deficits for respective cognitive domains
remains unclear, as well as whether the existing data sug-
gest global or more specific cognitive deficits. The present
paper offers a quantitative and qualitative review of the cur-
rent literature related to cognitive performance in PBD. The
quantitative review focuses on determining the magnitude
of PBD/control differences in neurocognitive domains, in-
cluding FSIQ and academic measures of reading. The qual-
itative review component focuses on other areas of interest,
including differences between individuals with PBD and
other conditions, identifying gaps in the literature, and de-
veloping recommendations for methodological reporting in
future studies of PBD.
Methods
We searched PsycInfo and PubMed using the terms “bipo-
lar” and “children or adolescents or youth” along with the
terms “cognitive” and “neuropsy*.” Additional studies were
garnered by reviewing the references of each article found.
Inclusion/exclusion criteria
There were no sample size-based inclusion or exclusion
criteria. Small studies can contribute to estimation of accu-
rate pooled effect sizes, even if they themselves are under-
powered. Studies were included in the quantitative analysis
only if they provided data for a healthy control group; com-
parisons using psychiatric control groups have been de-
scribed in the qualitatitive analyses.
Studies were excluded if the average age of the sample
was greater than 18 (n  2); primary outcome variables were
neurological soft signs, but not neuropsychological instru-
ments (n  1); the measure of neurocognitive functioning
was a behavioral checklist or questionnaire instead of a per-
formance task (n  1); and/or the study lacked an adequate
control group (n  1). One study was excluded because it
only examined mathematics performance; as no other stud-
ies specifically reported on this domain, meta-analysis was
not possible. Effect sizes for IQ were excluded if the study
reported intentionally matching subjects on IQ. For one
study (Olvera et al. 2005), IQ and neurocognitive differences
between PBD and controls were very large due to a very high
functioning control group (i.e., average FSIQ was 114 in the
control group, whereas 100 would be average performance
for the general population). This study was a clear outlier
and was excluded from subsequent analyses because of the
problem of having an exceptionally high-functioning control
group (the “super-controls” problem; Faraone et al. 1999). In
the event that a research group had published multiple man-
uscripts, only the study with the most complete data and/or
the largest sample size was included (n  2). When language
functioning was an outcome variable, only fluency was in-
cluded: The measures used to assess other language func-
tioning differed from those used for fluency and were idio-
syncratic across studies.
A total of 10 studies were identified that satisfied the in-
clusion and exclusion criteria. Table 1 presents the method-
ological characteristics of each study included in the meta-
analysis. Three studies contributed two bipolar versus
control comparisons: One study included separate unmed-
icated and medicated bipolar samples (Pavuluri et al. 2006),
another included bipolar only and bipolar plus attention-
deficit/hyperactivity disorder (ADHD) comparisons (Ruck-
lidge 2006), and a final study included euthymic and manic
bipolar samples (DelBello et al. 2004). These additional com-
parisons were included to increase generalizability of the
analyses and to facilitate post hoc comparisons examining the
influence of study characteristics on effect sizes. Although
nested effect sizes are best evaluated using hierarchical lin-
ear modeling, the small number of nested effect sizes and
the small overall sample suggested that little information
would be gained from this approach (Raudenbush and Bryk
2002).
Study coding
Exploratory post hoc analyses examined the influence of
study characteristics on effect sizes. The reviewer (T.F.)
recorded sample size as well as demographic characteristics







































































































































































































































































































































































































































































































































































































































































































































































and medication status. Percentages of the bipolar sample that
were co-morbid with ADHD and oppositional defiant dis-
order (ODD) were recorded. Differences in age between the
bipolar and control groups were calculated.
The nature of the bipolar sample varied across studies. The
type of BD diagnosis was assigned a value of 1 (bipolar I
only) or 2 (any bipolar spectrum). Mood criteria used to gen-
erate a bipolar diagnosis was also coded (1  elevated/eu-
phoric mood for all participants, 2  irritable mood only per-
mitted) to address the distinction that has been made
between “narrow” and “broad” phenotypes of PBD (Leiben-
luft et al. 2003). Additionally, the current mood of the sam-
ple was recorded when possible. If the study reported that
no or very few participants in the sample were experiencing
mania, a value of 0 was assigned. If the study reported that
a proportion of the sample was manic or gave a score range
for the Young Mania Rating Scale (YMRS) that overlapped
with the clinical range, a score of 0.5 was assigned. If the
study reported that the sample was primarily or completely
experiencing mania or the YMRS range fell well into the clin-
ical range, a score of 1 was assigned. An identical approach
was used for depression; the samples in three categories were
sorted on the basis of severity of depression.
Studies meeting inclusion/exclusion criteria were exam-
ined to determine the relative coverage of cognitive domains
across studies. Few studies included information regarding
affect recognition or social cognition; therefore, this domain
was excluded. The specific measures analyzed for each do-
main were based upon what was reported in identified stud-
ies. Studies varied in the number of measures reported, with
several studies reporting either aggregate or multiple mea-
sures within a particular cognitive domain. The domains
with best coverage across studies were: (1) FSIQ, (2) reading
achievement, (3) attention, (4) working memory, (5) execu-
tive functioning, (6) verbal memory, (7) visual memory, (8)
verbal fluency, (9) visual perceptual skills, and (10) motor
speed. For studies reporting multiple measures within a do-
main (for example, multiple CVLT scores evaluating verbal
memory), effect sizes were averaged across the relevant
scores evaluating that particular domain to create a single
effect size per sample (Lipsey and Wilson 2001). Table 2 dis-
plays the measures used to compute aggregate effect sizes.
Calculation of effect sizes
For each domain, we computed the standardized mean
difference in effect size using pooled standard deviations,
the Cohen d, with formulas provided in Lipsey and Wilson
(2001). The magnitude of effect sizes was defined by Cohen’s
(1988) criteria as small (d  0.2), medium (d  0.5), and large
(d  0.8). For each domain, we calculated the unweighted
mean, median, and weighted mean effect sizes along with
the 95% confidence interval (CI) for the weighted mean ef-
fect size. Homogeneity analyses were also computed for each
domain. The latter test evaluates whether the observed ef-
fect sizes likely result from sampling one population of ef-
fect sizes. For measures with heterogeneous distributions of
effect sizes, correlations between methodological factors and
effect sizes were performed to determine whether method-
ological characteristics were related to the magnitude of dif-
ferences between PBD and control groups (see Table 3). Cor-
relational analyses cannot establish causation and due to the
sparseness of the literature, we could not use regression to
try to parse how much variance was uniquely attributable
to a given factor. Given the exploratory nature of post hoc
analyses examining the influence of study and sample char-
acteristics, only large effects (r values  0.50) are interpreted.
Results
Table 4 presents meta-analytic results for all domains. All
domains showed a significant difference between PBD and
healthy controls (smallest z  2.22, p  0.014). However,
there were substantial differences in the magnitude of effects
across domains.
FSIQ and academic functioning
The magnitude of the mean, weighted mean, and median
effect sizes for FSIQ fell in the small to medium range. Ef-
fect sizes varied significantly across studies. Larger n stud-
ies produced smaller IQ differences (r  0.57). Qualitative
review of these data suggests that when differences were
found, they were usually due to youth with BD scoring
within the average range, though lower than the control sub-
jects (DelBello et al. 2004; Meyer et al. 2004; Doyle et al. 2005;
Voelbel et al. 2006). Extending beyond this quantitative re-
view, differences have not been found when comparing chil-
dren and adolescents with BD to young individuals with
other psychiatric disorders (McClellan et al. 2004). Addi-
tionally, co-morbidities such as ADHD and ODD likely play
a role in lowering scores on IQ tests by affecting performance
on the test and/or test session behavior ( Glutting et al. 1996;
Frazier et al. 2004).
Similar to findings for FSIQ, the magnitude of mean,
weighted mean, and median effect sizes for reading achieve-
ment fell in the small to medium range. Effect sizes did not
vary significantly across studies. Although not examined in
the quantitative review due to failing inclusion criteria, one
study found that youth with PBD experienced mathematics
deficits relative to individuals with major depressive disor-
der (MDD) and healthy comparison subjects (Lagace et al.
2003). Additionally, although school services were not ex-
amined quantitatively, qualitative review indicated that PBD
youth also required more school services such as tutoring
and placement in special classes than healthy comparison
youth (Doyle et al. 2005), and youth with PBD and co-mor-
bid ADHD required more school services than youth with
ADHD alone (Henin et al. 2007).
Attention, motor speed, and executive function
The magnitude of mean, weighted mean, and median ef-
fect sizes for attention fell in the medium range. Effect sizes
varied substantially across studies (d ranging from 0.31 to
1.15). Analysis of this variability did not reveal any major
contributors, although inclusion of the bipolar spectrum
rather than just bipolar I disorder was associated with larger
effects for deficits in attention. This was unexpected, given
that bipolar spectrum disorders might be considered less im-
paired with respect to mood than bipolar I; yet inclusion of
these cases yielded stronger effects for impairments in at-
tention. Studies in which all or nearly all of the bipolar group
had ADHD tended to contribute the largest effect sizes
(Doyle et al. 2005; Rucklidge 2006; Henin et al. 2007), but this
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TABLE 2. MEASURES USED TO CALCULATE AGGREGATED EFFECT SIZES
Study PBD (n) Aggregated measures
Attention
DelBello et al. 10 CPT 0% degradation: discrimination, % correct, false positives
(2004) 10
Doyle et al. (2005) 57 Digit Symbol, Symbol Search, CPT vigilance
Henin et al. (2007) 73 Digit Symbol, Symbol Search, CPT vigilance
Pavuluri et al. (2006) 28 TMT Part A: Time and Penn CPT true positives and false positives
28
Rucklidge et al. (2006) 12 CPT omissions, RAN variables, and PSI
12
Working Memory
Bearden et al. (2007) 33 Digits Forward and Digits Backward
Dickstein et al. (2004) 21 Spatial Span total errors, span length, total usage errors and Spatial
Working Memory strategy and total errors
Doyle et al. (2005) 57 Digit Span and Arithmetic
Henin et al. (2007) 73 Digit Span and Arithmetic
Pavuluri et al. (2006) 28 WMS-III Digit Span raw score and Spatial Span raw score
28
Rucklidge et al. (2006) 12 Digit Span and Arithmetic
12
Executive Function
Dickstein et al. (2004) 21 Intra-Extradimentional Shift variables and Stockings of Cambridge variables
Doyle et al. (2005) 57 WCST categories, perseverative errors, non-perseverative errors, and
failure to maintain set and Stroop color-word and interference
Henin et al. (2007) 73 WCST categories, perseverative errors, non-perseverative errors, and
failure to maintain set and Stroop color-word and interference
McClure et al. (2005) 35 CPT A-X response bias, discriminability, CPT flanker reaction time
cost, Identical pairs CPT response bias, Stop Signal Test reaction time
and change reaction time
Pavuluri et al. (2006) 28 Set Shifting total errors, Penn Conditional Exclusion Test total errors,
Trail Making Test Part B: time, Controlled Oral Word Association
28 Test: raw score
Rucklidge et al. (2006) 12 Stroop color-word and interference; Color Trails variables; WCST
12 categories, perseverative errors and conceptual level responses; CPT
commissions, task response variability and confidence index
Voelbel et al. (2006) 12 Category Test, TMT-Part B/PFT, Stroop Color Word correct, WCST-
Categories, WCST-Perseverative errors
Verbal Fluency
Bearden et al. (2007) 33 FAS, animals and boys’ names, and switching
Voelbel et al. (2006) 12 Phonemic and semantic fluency measures
Verbal Memory
Glahn et al. (2005) 21 CVLT all learning trials averaged
McClure et al. (2005) 35 CVLT and TOMAL
Pavuluri et al. (2006) 28 CVLT-C trials 1–5, short delay, long delay
28
Rucklidge et al. (2006) 12 WRAML story memory and verbal learning
12
(continued)
was not universally the case (Pavuluri et al. 2006). It is also
important to note that qualitative review showed that in four
different studies, differences in attention failed to be identi-
fied when a psychiatrically diagnosed comparison group
was used. (e.g., ADHD, autism spectrum disorders, MDD,
psychosis not otherwise specified [NOS], and schizophrenia)
(Robertson et al. 2003; McClellan et al. 2004; Voelbel et al.
2006; Henin et al. 2007).
Motor speed differences between PBD and controls were
small in magnitude. Effect sizes did not vary significantly
across studies. Qualitative review highlights that in one case
a group that had both ADHD and PBD showed impaired
motor speed abilities, whereas those with PBD alone did not
(Rucklidge 2006). Additionally, when PBD was compared to
other clinical disorders such as psychotic disorders, ADHD,
conduct disorder, and ODD, no differences were found (Mc-
Carthy et al. 2004).
Effect sizes for executive function were based upon mea-
sures of planning, organization, response inhibition, and set
shifting. Executive function differences between PBD and
controls were moderate in magnitude and did not vary sig-
nificantly across studies. Qualitative review highlights that
executive function impairments were found in both
ADHD–co-morbid and non-ADHD–co-morbid groups
(Shear et al. 2002; Meyer et al. 2004; Bearden et al. 2006; Pavu-
luri et al. 2006) , and in both medicated and unmedicated in-
dividuals (Pavuluri et al. 2006). In contrast to results found
when youth with BD were compared to healthy controls, ex-
ecutive function deficits were not found on the Wisconsin
Card Sorting Test (WCST) when an MDD comparison group
was used (Meyer et al. 2004), nor when comparison groups
of schizophrenia or psychosis NOS were used (McClellan et
al. 2004). The heterogeneity in executive functioning mea-
sures used within and across studies made interpretations
complicated. Inspection of the individual study findings in-
dicates that some measures show larger effects whereas oth-
ers show no significant effect or small effects. Unfortunately,
no reliable pattern of specific executive function deficits
could be discerned.
Working memory
The magnitude of mean, weighted mean, and median ef-
fect sizes for working memory fell in the medium to large
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TABLE 2. MEASURES USED TO CALCULATE AGGREGATED EFFECT SIZES (CONT’D)
Study PBD (n) Aggregated measures
Visual Memory
Dickstein et al. (2004) 21 Spatial and Pattern Recognition Memory mean correct latency and
percent correct
McClure et al. (2005) 35 Rey-Osterreith delayed memory, TOMAL, and face memory
Pavuluri et al. (2006) 28 Penn face memory task, facial recognition task, immediate and
28 delayed facial recognition total scores
Rucklidge et al. (2006) 12 WRAML Visual Memory Index
12
Motor Speed
Pavuluri et al. (2006) 28 Finger tapping right and left hand total taps
28
Visual-Perceptual Skills
Doyle et al. (2005) 57 Rey-Osterreith copy and delay organization
Henin et al. (2007) 73 Rey-Osterreith copy and delay organization
CPT  Continuous Performance Task; CVLT  California Verbal Learning Test; PFT  Progressive Figures Test; PSI  Processing Speed
Index (Wechsler Intelligence Scales for Children); RAN  Rapid Automatized Naming; TMT-B  Trail Making Test B; TOMAL  Test of
Memory and Learning; WCST  Wisconsin Card Sorting Test; WRAML  Wide Range Assessment of Memory and Learning.
TABLE 3. RELATIONSHIP BETWEEN METHOD VARIABLES AND EFFECT SIZE FOR HETEROGENEOUS DOMAINS
Study % % BP diagnosis
Domain (n) ADHD Medicated Manic Depressed typea
FSIQ 0.57 0.33 0.23 0.29 0.25 0.28
Attention 0.17 0.34 0.31 0.39 0.39 0.43
Working memory 0.62 0.39 0.15 0.08 0.02 0.45
Verbal memory 0.49 0.01 0.03 0.35 0.35 0.39
aBipolar spectrum versus BP I only.
ADHD  attention-deficit/hyperactivity disorder; BP  bipolar disease; FSIQ  full-scale intelligence quotient.
range. Effect sizes varied minimally across studies (homo-
geneity p  0.08), but larger n studies tended to produce
smaller effects (r  0.62). Qualitative review showed that
in one study children and adolescents with BD failed to dem-
onstrate differences unless they also had co-morbid ADHD
(Rucklidge 2006). In a study using a clinical comparison
group made up of youths with psychotic disorders, ADHD,
conduct disorder, and ODD, there were no differences in
working memory ability (McCarthy et al. 2004).
Verbal fluency and visual perceptual skills
Only two effect sizes were identified for verbal fluency
(d  0.24 and 0.52), making conclusions regarding this do-
main especially tentative. Preliminarily, verbal fluency ap-
pears to show small to medium differences between PBD
and controls. Similarly, only four studies yielded effect sizes
for visual perceptual skills (see Table 2). A medium effect
was observed for the difference between PBD and controls.
Visual and verbal long-term memory
Visual memory effect sizes fell in the medium range,
whereas verbal memory effect sizes were large in magnitude.
Effect sizes for verbal memory showed a trend toward het-
erogeneity (p  0.08), and this was most strongly associated
with larger n studies producing smaller effect sizes (r 
0.49). Inspection of studies examining verbal memory in-
dicated that the percentage of participants with ADHD or
on medicine did not moderate this effect (r values  0.05).
This may imply that verbal memory deficits are more spe-
cific to BD.
Discussion
The goal of this paper was to review the literature about
neurocognitive functioning in PBD, using a combination of
quantitative methods where possible, supplemented by a
qualititative analysis. The literature search yielded 10 stud-
ies that contributed to the quantitative analyses. Findings
were broadly consistent with conclusions of two recent meta-
analyses of neurocognitive functioning in adult BD (Robin-
son et al. 2006; Arts et al. 2007), and generally indicated that
PBD is associated with deficits in functioning compared to
healthy controls. This consistency is reassuring corrobora-
tive evidence for the validity of research diagnoses of PBD.
It was difficult to identify neurocognitive deficits that might
be specific to PBD based on the extant literature.
Verbal memory measures showed the largest difference
between PBD and controls. This is consistent with the adult
literature examining neurocognitive deficits in BD (Robin-
son et al. 2006; Arts et al. 2007). The weighted mean effect
size for verbal memory is quite consistent with those re-
ported in the adult literature: d  0.77 here versus d  0.85
(Arts et al. 2007) and d  0.71–0.90 (depending on the mea-
sure) (Robinson et al. 2006). These data are also consistent
with fronto-limbic abnormalities identified in adolescents
and adults with BD (Caetano et al. 2005; Frazier et al. 2005;
Monkul et al. 2005; Kyte et al. 2006; Frey et al. 2007). This
pattern of results indicates that verbal memory deficits are
not likely to be solely a consequence of chronic course or
long-term treatment of BD. However, these data do not speak
to whether verbal memory deficits precede the onset of the
illness. Future studies are needed to examine this more care-
fully.
Several other measures showed moderate effects, includ-
ing attention, working memory, executive function, visual
memory, and visual-perceptual skills. Although these mod-
erate differences emerged when comparing youth with BD
to healthy controls, qualitative review suggested that differ-
ences were not found when psychiatric comparison groups
were used, particularly for attention. Attention deficits may
not be specific to PBD, but may represent findings for gen-
eral psychopathology (Arts et al. 2007).
Small effects were found for FSIQ, reading achievement,
and motor speed. The data for FSIQ in pediatric subjects re-
ported here are consistent with those reported in adults: Both
suggest little difference in the overall ability of individuals
with BP and controls. Meta-analyses of adult data have
found d  0.16–0 .19 (Robinson et al. 2006; Arts et al. 2007).
Confounds in the literature
Though this meta-analysis found neurocognitive deficits
in PBD, there remain several concerns about possible con-
founds in the literature. The potential impact of these con-
founds is great enough that we recommend interpreting the
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TABLE 4. MEAN AND WEIGHTED MEAN EFFECT SIZES FOR COMPARISON OF CASES WITH BIPOLAR VERSUS
HEALTHY CONTROLS, THE 95% CONFIDENCE INTERVALS (CIS), AND TESTS OF HOMOGENEITY (Q)
n k effect Weighted 95%
Domain studies sizes M M Md CI z Q
FSIQ 10 14 0.52 0.32 0.41 0.17–0.47 4.29 27.66a
Reading achievement 3 4 0.40 0.40 0.39 0.20–0.60 3.95 0.10
Attention 6 9 0.70 0.62 0.51 0.45–0.78 7.27 15.86a
Motor speed 4 7 0.37 0.33 0.34 0.09–0.58 2.71 8.21
Executive function 8 10 0.62 0.55 0.56 0.39–0.70 6.93 8.52b
Working memory 6 8 0.75 0.60 0.80 0.44–0.77 7.13 12.72b
Verbal fluency 2 2 0.38 0.45 — 0.05–0.85 2.22 —
Visual-perceptual skills 3 4 0.51 0.48 0.52 0.19–0.77 2.91 1.45
Visual memory 5 7 0.51 0.51 0.52 0.30–0.72 4.69 2.39
Verbal memory 6 8 0.88 0.77 0.78 0.59–0.94 8.70 11.33b
ap  .05
bp  .08
results of this meta-analysis with caution. First, as mentioned
above, the use of healthy control comparison groups sets up
an artificial contrast that may speak only to deficits associ-
ated with general psychopathology, not deficits specific to
BD (Youngstrom et al. 2006). This is a limitation in the adult
literature as well, where deficits are also not found when
psychiatric comparison groups are used (Krabbendam et al.
2005; Bearden et al. 2006; Depp et al. 2007; Schretlen et al.
2007). There is some evidence that cognitive deficits reported
in the literature on PBD are also experienced by youths with
other disorders (Martinussen and Tannock 2006; Shanahan
et al. 2006; Jakobson and Kikas 2007; Mahone and Hoffman
2007). Future research studies in this area should include
comparison groups made up of clinically referred children.
The most useful design for identifying features specific to
PBD would include comparison groups made up of youths
with disorders that are challenging in the differential diag-
nosis of BD, such as ADHD, MDD, ODD, and schizophre-
nia.
Second, aggregating extant studies may cause an “apples
to oranges” problem at the diagnostic construct level. Cur-
rently, there is no consensus statement regarding “true” di-
agnostic criteria for PBD (Youngstrom et al. 2008), and we
do not yet know whether BD with irritability as the only
mood symptom is a qualitatively different entity from BD
with euphoria (Leibenluft et al. 2003). Mirroring a lack of
consensus in the field in general, research groups are not
consistent with regard to diagnostic inclusion criteria, and
accordingly there are a wide variety of clinical presentations
of BD across research studies. If there are indeed different
subtypes of PBD with important phenomenological differ-
ences, then it is quite possible that there are distinct neu-
rocognitive profiles associated with the subtypes, and the
different definitions used by researchers could lead directly
to the differences observed in findings. At present, there are
no studies we found that look at neurocognitive differences
between bipolar I, II, or NOS in pediatric samples, nor that
directly compare neurocognition in the broad versus narrow
phenotypes. The comparisons between BD and “severe
mood dysregulation” (which originally was conceptualized
as part of the “broad phenotype” but now appears to be a
more specific entity that involves non-bipolar mood dysreg-
ulation) suggest both that many neurocognitive deficits will
be nonspecific, and also that it may be possible to identify
more discrete processes affected by BD (such as more focal
emotion processes) (Rich et al. 2005a; Rich et al. 2005b; Dick-
stein and Leibenluft 2006; Brotman et al. 2007; Brotman et al.
2008). Although it is ambiguous whether the “severe mood
dysregulation” construct is on the bipolar spectrum, it would
be highly productive to adopt similar methods to investigate
whether there are differences between putative subtypes
within the bipolar spectrum.
Third, ADHD co-morbidity appears to be a significant con-
founding factor when attempting to measure neuropsycho-
logical performance in youths with BD. Given high rates of
co-morbidity (averaging 62% in a meta-analysis of seven
studies) (Kowatch et al. 2005), neuropsychological deficits re-
ported in PBD may actually be the result of impairments due
to ADHD. To date only one study has directly examined this
possibility, concluding that there were “few, if any, differ-
ences” between the co-morbid and ADHD-only groups (p.
216 in Henin et al. 2007), which suggests that ADHD co-mor-
bidity may play a larger role in cognitive and neuropsycho-
logical deficits in BD than has been explored yet in the lit-
erature. A study that explores all possible combinations of
ADHD and BD is necessary for further elucidating the com-
plex relationship between these two disorders and the re-
sulting effects on neuropsychological functioning in children
and adolescents. The present data suggest that verbal mem-
ory deficits are likely the most specific finding to BD, as in-
dividuals with ADHD show minimal deficits in this domain
(Seidman et al. 1997). Research has yet to address adequately
whether the overlapping symptomatology and neurocogni-
tive impairments, among other similarities, seen in ADHD
and BD may actually be a result of a common underlying
disruption in neural circuitry. Future studies addressing this
question with neuroimaging techniques are greatly needed.
Finally, the literature does not yet speak to the effects of
medication or mood state on neurocognitive performance,
let alone long-term development, in youths with PBD.
Limitations
The present quantitative review did not examine measures
of emotional processes. Some data suggest that individuals
with PBD have difficulty with social cognition, including
problems labeling facial emotions (McClure et al. 2003; Mc-
Clure et al. 2005b) and social skills performance deficits
(Goldstein et al. 2006). Additional research is needed exam-
ining specific social cognition skills to determine which
deficits are specific to BD.
Additionally, this meta-analysis aggregated measures in
several cases; although this was done within domains, com-
bining different measures may have diluted some effects by
reducing specificity of the aggregated effect sizes. However,
given the limited number of studies available, aggregation
was necessary to increase reliability of the findings. As this
literature further develops, future meta-analyses can exam-
ine individual neuropsychological measures rather than
broad cognitive domains, as has been done in ADHD (Fra-
zier et al. 2004). This work will hopefully be able to include
more specific social cognition, attention, and executive func-
tioning measures to determine what aspects of these do-
mains may be most impaired in PBD. Finally, the review was
limited in its ability to address questions pertaining to psy-
chosis, due to the limited information reported in the litera-
ture.
Recommendations for future study reporting
One of the most significant limitations of this meta-anal-
ysis was the lack of consistency in reporting of results by
studies found within the neurocognitive literature for PBD.
Specifically, sample and methodological characteristics var-
ied widely and demonstrated significant correlations with
effect sizes, suggesting that these differences in study char-
acteristics may contribute to the inconsistencies in published
findings. To reduce variability and increase generalizability,
future studies of neurocognitive performance in PBD should
provide a detailed report of: (1) diagnostic criteria used for
inclusion; (2) medication status of participants; (3) current
mood state of participants (both manic and depressed
moods); and (4) psychiatric co-morbidities, especially
ADHD. The diagnostic debate within PBD is not likely to be
resolved quickly; therefore, while different sets of diagnos-
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tic criteria continue to be used, detailed reporting is crucial
to facilitate comparing studies. Ideally, given the potential
effects of pharmacological treatment on neuropsychological
performance as well as uncertainty about the long-term brain
effects of medication treatment for BD, future neuropsycho-
logical studies in PBD ideally should include both medicated
and unmedicated subjects separated out by medication sta-
tus. It is also important to understand whether observed
deficits are “state” or “trait” impairments.
Beginning with Emil Kraepelin, data suggest that neu-
rocognitive performance may fluctuate along with affective
symptoms over the course of bipolar illness. To make the
distinction between lifetime diagnosis versus mood state ef-
fects, mood status should remain consistent within groups
and ideally be compared between groups within the same
study. Similarly, psychiatric co-morbidities, particularly
ADHD, may significantly “muddy the waters” when mea-
suring neurocognitive impairments. ADHD status should
likewise be documented consistently and ideally be com-
pared between groups within each study. Spurious findings
may be avoided by rigorously controlling for these poten-
tially powerful methodological confounds, and these factors
are much better disentangled by changes in design rather
than post hoc statistical adjustments. There have been gen-
eral reporting guidelines offered for clinical trials (e.g., CON-
SORT) and diagnostic studies (STARD) (Bossuyt et al. 2003).
What we are suggesting is a brief, adjunctive set of key de-
sign features that could be routinely reported to accelerate
progress in integrating findings around neurocognition and
PBD.
Future directions
Future studies of neurocognition in PBD should target
several important research questions. First, determining
which deficits or markers precede symptom onset remains
a crucial point of understanding for both adult and PBD. A
related question is whether changes in neurocognitive func-
tioning are the result of normal developmental processes, the
progression of the disease, pharmacological treatment, or
some combination of the above. Long-term, prospective
studies of at-risk populations are essential for getting a clear
understanding of whether cognitive and neuropsychological
deficits are “state” or “trait” phenomena. Additionally, such
studies would allow for analyses of the neurobiological ef-
fects of recurrent mood episodes and pharmacological treat-
ments.
Additionally, future work should examine whether neu-
rocognitive deficits exist in healthy siblings, similar to find-
ings in the adult literature (Arts et al. 2007). Finding deficits
in first-degree relatives may lend credibility to neurocogni-
tive abnormalities as an endophenotype for BD (Glahn et al.
2005; Christensen et al. 2006; Antila et al. 2007; Trivedi et al.
2008). Failing to find deficits might support the hypothesis
that identified neurocognitive abnormalities are simply a
marker of generally disrupted functioning in psychopathol-
ogy.
Finally, although studies have shown abnormal structure
and function in youth with PBD (Chang et al. 2004; DelBello
et al. 2004; Caetano et al. 2005; Dickstein et al. 2005), it is im-
portant to link neurocognitive processes with these neuro-
biological abnormalities by demonstrating correlations be-
tween neurocognitive deficits and structural magnetic reso-
nance imaging (MRI) findings as well as studies examining
neural correlates of cognitive functions in vivo using func-
tional (f)MRI. These connections will elucidate the patho-
physiology of PBD, and hopefully will inform more effective
treatments as well as assessment strategies.
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